Latest News

VOYAGER PAD analyses shed light on use of rivaroxaban in high-risk...

New analyses from the VOYAGER PAD clinical trial in both high-risk and fragile patients and those with and without comorbid coronary artery diseases (CAD)...

From the Editor

Happiness

Can you count the ‘monkeys’ on your back?

Periodically, when under pressure at work, and sometimes at home, I would think about what I could do to free up more time for...

From the editor: Sex, lies, and carotid stents

First, a disclaimer. This commentary is woefully short of sex-related content. Not even the wholesome gender-based outcomes stuff. So, if that key term brought...

SVS news

VRIC submissions are now open

Researchers may now submit abstracts for the SVS Vascular Research Initiatives Conference (VRIC), to be held in conjunction with the American Heart Association’s...

SVS 2024 dues renewal deadline approaches

SVS members are reminded to act promptly before the year’s end to ensure uninterrupted access to their 2024 membership benefits. Renewals are due on...

Commentary

Change is a constant in life, and advocacy is no exception. The healthcare landscape is always evolving, and the SVS Advocacy Council is working to maintain a voice in the decision-making process. The council is committed to driving change...

VAM news

Organizing a Vascular Annual Meeting (VAM) takes a whole lot of time and a whole lot of long-range planning.  Thus, members of the SVS Postgraduate Education Committee (PGEC) have already evaluated the 90 submitted proposals (an SVS record) for educational...